Quantessence Capital’s Mondelez International MDLZ Stock Holding History

Quantessence Capital’s Portfolio MDLZ Stock Details MDLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-55,300	Closed	-$3.75M	–	344
2025 Q1	$3.75M	Buy	+55,300	New	+$3.41M	0.94%	20

Other funds holding MDLZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantessence Capital's MDLZ Position: Q2 2025 in Review

Quantessence Capital sold out of Mondelez International (MDLZ) in Q2 2025, closing a stake of 55,300 shares — an estimated $3.75M sold.

Quantessence Capital first reported a position in MDLZ in Q1 2025 and held it in 1 quarter. The position peaked at $3.75M in Q1 2025. 1,987 funds tracked by Wall St. Rank hold MDLZ as of Q2 2025.

Quantessence Capital reported no remaining Mondelez International position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 55,300 Mondelez International shares in Q2 2025, an estimated $3.75M.
Quantessence Capital first reported a position in Mondelez International in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Mondelez International position peaked at $3.75M in Q1 2025.
1,987 funds tracked by Wall St. Rank held Mondelez International as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.